There is a persistent gap between preclinical promise and clinical reality in oncology drug development. Two-dimensional cell culture systems derived from animal mod...

Self-administered injectable drug–device combination (DDC) products are entering a phase of accelerated therapeutic innovation. Demographic change, chronic disease t...

Clinical trial monitoring has traditionally relied on routine on site visits and exhaustive source data verification (SDV) to ensure patients’ safety and data integr...

From Episodic Challenges to Structural Conditions in Clinical Research sites remain indispensable as the operational backbone of the clinical trial ecosystem. They a...